158 related articles for article (PubMed ID: 8355396)
1. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.
Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S
Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396
[TBL] [Abstract][Full Text] [Related]
2. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
[TBL] [Abstract][Full Text] [Related]
3. High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease.
Miyata M; Biro S; Arima S; Hamasaki S; Kaieda H; Nakao S; Kawataki M; Nomoto K; Tanaka H
Am Heart J; 1996 Aug; 132(2 Pt 1):269-73. PubMed ID: 8701886
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a).
Yamamoto H; Imazu M; Yamabe T; Ueda H; Hattori Y; Yamakido M
Am Heart J; 1995 Dec; 130(6):1168-73. PubMed ID: 7484765
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E
Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
[TBL] [Abstract][Full Text] [Related]
10. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty.
Boullier A; Walters-Laporte E; Hamon M; Tailleux A; Amant C; Amouyel P; Fruchart J; Bertrand M; Duriez P
Clin Chim Acta; 2000 Sep; 299(1-2):129-40. PubMed ID: 10900299
[TBL] [Abstract][Full Text] [Related]
11. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group.
Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y
Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026
[TBL] [Abstract][Full Text] [Related]
12. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.
Chiarugi L; Prisco D; Antonucci E; Capanni M; Fedi S; Liotta AA; Margheri M; Simonetti I; Gensini GF; Abbate R
Atherosclerosis; 2001 Jan; 154(1):129-35. PubMed ID: 11137091
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
[TBL] [Abstract][Full Text] [Related]
15. The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial.
Lloyd GW; Jackson G; Foley DP; Boersma E; Shepherd J; Serruys PW
Atherosclerosis; 2001 Oct; 158(2):445-54. PubMed ID: 11583725
[TBL] [Abstract][Full Text] [Related]
16. Prevention of restenosis by bezafibrate after successful coronary angioplasty.
Ishiwata S; Nakanishi S; Nishiyama S; Seki A
Coron Artery Dis; 1995 Nov; 6(11):883-9. PubMed ID: 8696533
[TBL] [Abstract][Full Text] [Related]
17. [Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis].
Ishikawa Y; Fujioka Y; Kitagawa Y; Nobusawa A; Takahashi A; Taniguchi T; Yokoyama M
Nihon Ronen Igakkai Zasshi; 1995 Jul; 32(7):491-6. PubMed ID: 7500552
[TBL] [Abstract][Full Text] [Related]
18. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
[TBL] [Abstract][Full Text] [Related]
19. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
